Skip to main content
. 2019 Dec 6;11(12):1961. doi: 10.3390/cancers11121961

Figure 2.

Figure 2

Genes associated with the mesenchymal phenotype of CTCs had a negative impact on survival (A) and recurrence (BE) in patients in a BRCA cohort of The Cancer Genome Atlas (TCGA). Low/moderate status of gene expression relative to the first quartile (Q1); low/high status of gene expression relative to the third quartile (Q3); hazard ratios (HR) with 95% confidence intervals (95% CI) computed using Cox proportional hazards regression; OS: overall survival, DFS: disease-free survival.